Showing results (21-30 of 91) with videos related to
Sort By:
Pageof 10
Alcohol and Alcoholism (Oxford, Oxfordshire)|August 9, 2023
Neuroanatomical predictors of problematic alcohol consumption in adolescents: a systematic review of longitudinal studiesFaraz Honarvar, Saman Arfaie, Hanie Edalati, et al.Journal of Affective Disorders|March 7, 2026
Evaluating the potential of applying artificial intelligence in the diagnosis of major depressive disorder: Neuroimaging and clinical behavioral markersYang Jing Zheng, Christine E Dri, Angela T H Kwan, et al.Journal of Affective Disorders|May 21, 2024
The role of KCNQ channel activators in management of major depressive disorderShakila Meshkat, Angela T H Kwan, Gia Han Le, et al.CNS Spectrums|October 31, 2024
Efficacy of esketamine for perinatal depression: a systematic review and meta-analysisSabrina Wong, Gia Han Le, Angela T H Kwan, et al.Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|June 12, 2025
A real-world population-based study on the association between cataracts and antipsychoticsMoiz Lakhani, Angela T H Kwan, Emaan Chaudry, et al.CNS Drugs|October 4, 2023
Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical TrialsDania Akbar, Taeho Greg Rhee, Felicia Ceban, et al.Psychiatric Research and Clinical Practice|June 23, 2025
Major Depressive Disorder in Long COVID and Exposure to Pro-Inflammatory Cytokines During Infection by SARS-CoV-2Hernan F Guillen-Burgos, Juan F Gálvez-Flórez, Sergio Moreno-López, et al.CNS Spectrums|November 20, 2024
Ketamine for the Treatment of Psychiatric Disorders: A Systematic Review and Meta-AnalysisAngela T H Kwan, Moiz Lakhani, Gurkaran Singh, et al.The American Journal of Psychiatry|January 1, 2025
Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future ResearchRoger S McIntyre, Angela T H Kwan, Rodrigo B Mansur, et al.Journal of Affective Disorders|December 5, 2024
Efficacy of orexin antagonists for the management of major depressive disorder: A systematic review of randomized clinical trialsShakila Meshkat, Angela T H Kwan, Gia Han Le, et al.Pageof 10